Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

A “MOLECULAR shield” placed in the nose could prevent hay fever symptoms, a study suggests. Scientists have engineered an ...

With a new leadership team and fast-track designation from the US Food and Drug Administration (FDA), clinical-stage oncology ...

Every three minutes, about one person is diagnosed with a form of blood cancer for which the treatment could require a bone ...

Patients who receive avacopan for antineutrophil cytoplasmic antibody-associated vasculitis demonstrate fewer infections and ...